99 related articles for article (PubMed ID: 28577090)
1. Circulating Proteasomes in the Pathogenesis of Head and Neck Squamous Cell Carcinoma.
Kakurina GV; Cheremisina OV; Choinzonov EL; Kondakova IV
Bull Exp Biol Med; 2017 May; 163(1):92-94. PubMed ID: 28577090
[TBL] [Abstract][Full Text] [Related]
2. Activity and subunit composition of proteasomes in head and cervical squamous cell carcinomas.
Spirina LV; Kondakova IV; Choinzonov EL; Sharova NP; Chigevskay SY; Shishkin DA
Bull Exp Biol Med; 2010 Jul; 149(1):82-5. PubMed ID: 21113465
[TBL] [Abstract][Full Text] [Related]
3. Adenylyl Cyclase-Associated Protein 1 in the Development of Head and Neck Squamous Cell Carcinomas.
Kakurina GV; Kondakova IV; Cheremisina OV; Shishkin DA; Choinzonov EL
Bull Exp Biol Med; 2016 Mar; 160(5):695-7. PubMed ID: 27021082
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of TATI and CYFRA 21-1 in patients with head and neck squamous cell carcinoma.
Goumas PD; Mastronikolis NS; Mastorakou AN; Vassilakos PJ; Nikiforidis GC
ORL J Otorhinolaryngol Relat Spec; 1997; 59(2):106-14. PubMed ID: 9166881
[TBL] [Abstract][Full Text] [Related]
5. Serum levels of interleukin-6 in patients with primary head and neck squamous cell carcinoma.
Riedel F; Zaiss I; Herzog D; Götte K; Naim R; Hörmann K
Anticancer Res; 2005; 25(4):2761-5. PubMed ID: 16080523
[TBL] [Abstract][Full Text] [Related]
6. Serum levels of interleukins 4 and 10 in head and neck squamous cell carcinoma.
Mojtahedi Z; Khademi B; Yehya A; Talebi A; Fattahi MJ; Ghaderi A
J Laryngol Otol; 2012 Feb; 126(2):175-9. PubMed ID: 21888745
[TBL] [Abstract][Full Text] [Related]
7. Serum levels of tumor necrosis factor in squamous cell carcinoma of the head and neck.
Soylu L; Ozcan C; Cetik F; Paydaş S; Kiroğlu M; Aydoğan B; Sargin O; Ozşahinoglu C; Seyrek E
Am J Otolaryngol; 1994; 15(4):281-5. PubMed ID: 7978027
[TBL] [Abstract][Full Text] [Related]
8. Inverse correlation between serum PGE2 and T classification in head and neck cancer.
Hambek M; Baghi M; Wagenblast J; Schmitt J; Baumann H; Knecht R
Head Neck; 2007 Mar; 29(3):244-8. PubMed ID: 17123309
[TBL] [Abstract][Full Text] [Related]
9. [Peripheral blood circulating tumor cells in local advanced head and neck squamous cell carcinoma].
Lou JL; Guo L; Zheng WH; Zhao JZ; Zhao JQ; Liang Z; Wang SY; Fang MY
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Nov; 52(11):824-829. PubMed ID: 29141291
[No Abstract] [Full Text] [Related]
10. Circulating tumor cells as biomarkers of head and neck squamous cell carcinoma: an updated view.
Mangano A; Mangano A; Lianos GD; Levrini L; Picone M; Boni L; Dionigi G
Future Oncol; 2015; 11(13):1851-3. PubMed ID: 26161921
[No Abstract] [Full Text] [Related]
11. Prospective study of a panel of tumor markers as prognostic factors in patients with squamous cell carcinoma of head and neck.
Kandiloros D; Eleftheriadou A; Chalastras T; Kyriou L; Yiotakis I; Ferekidis E
Med Oncol; 2006; 23(4):463-70. PubMed ID: 17303904
[TBL] [Abstract][Full Text] [Related]
12. Association between squamous cell carcinoma of the head and neck and serum folate and homocysteine.
Eleftheriadou A; Chalastras T; Ferekidou E; Yiotakis I; Kyriou L; Tzagarakis M; Ferekidis E; Kandiloros D
Anticancer Res; 2006; 26(3B):2345-8. PubMed ID: 16821614
[TBL] [Abstract][Full Text] [Related]
13. Elevated serum levels of M30 and M65 in patients with locally advanced head and neck tumors.
Ozturk B; Coskun U; Sancak B; Yaman E; Buyukberber S; Benekli M
Int Immunopharmacol; 2009 May; 9(5):645-8. PubMed ID: 19249390
[TBL] [Abstract][Full Text] [Related]
14. Serum nitric oxide levels in patients with head and neck squamous cell carcinoma.
Kizilay A; Kalcioğlu MT; Ozuğurlu F; Ozyurt H; Aladağ I; Ozturan O; Akyol O
Kulak Burun Bogaz Ihtis Derg; 2007; 17(3):148-51. PubMed ID: 17873505
[TBL] [Abstract][Full Text] [Related]
15. Serum biomarkers in head and neck squamous cell cancer.
Kaskas NM; Moore-Medlin T; McClure GB; Ekshyyan O; Vanchiere JA; Nathan CA
JAMA Otolaryngol Head Neck Surg; 2014 Jan; 140(1):5-11. PubMed ID: 24232368
[TBL] [Abstract][Full Text] [Related]
16. The significance of Tenascin-C serum level as tumor marker in squamous cell carcinoma of the head and neck.
Pauli C; Stieber P; Schmitt UM; Andratschke M; Hoffmann K; Wollenberg B
Anticancer Res; 2002; 22(5):3093-7. PubMed ID: 12530049
[TBL] [Abstract][Full Text] [Related]
17. Epithelial cells in the peripheral blood of patients with cancer of the head and neck: incidence, detection and possible clinical significance.
Pajonk F; Schlessmann S; Guttenberger R; Henke M
Radiother Oncol; 2001 May; 59(2):213-7. PubMed ID: 11325451
[TBL] [Abstract][Full Text] [Related]
18. Serum concentrations of laminin gamma2 fragments in patients with head and neck squamous cell carcinoma.
Kuratomi Y; Sato S; Monji M; Shimazu R; Tanaka G; Yokogawa K; Inoue A; Inokuchi A; Katayama M
Head Neck; 2008 Aug; 30(8):1058-63. PubMed ID: 18446818
[TBL] [Abstract][Full Text] [Related]
19. [Effect of tissue inhibitors of metalloproteinases (TIMP) on course and prognosis of head and neck squamous cell carcinoma].
Klisho EV; Kondakova IV; Choĭnzonov EL; Shishkin DA; Cheremisina OV; Chuzhevskaia SIu
Vopr Onkol; 2009; 55(6):717-21. PubMed ID: 20210014
[TBL] [Abstract][Full Text] [Related]
20. SCC-RIA in the diagnosis of squamous cell carcinoma of the head and neck.
Eibling DE; Johnson JT; Wagner RL; Su S
Laryngoscope; 1989 Feb; 99(2):117-24. PubMed ID: 2913421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
